These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1282 related articles for article (PubMed ID: 29706964)

  • 1. Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis.
    Vallée A; Lecarpentier Y
    Front Immunol; 2018; 9():745. PubMed ID: 29706964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.
    Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
    Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):853-866. PubMed ID: 28981597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the Canonical WNT/β-Catenin Pathway in Cancer Treatment Using Non-Steroidal Anti-Inflammatory Drugs.
    Vallée A; Lecarpentier Y; Vallée JN
    Cells; 2019 Jul; 8(7):. PubMed ID: 31311204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-γ ligands via Wnt signaling pathway.
    Liu JJ; Dai XJ; Xu Y; Liu PQ; Zhang Y; Liu XD; Fang ZG; Lin DJ; Xiao RZ; Huang RW; Huang HQ
    Cell Biochem Biophys; 2012 Jan; 62(1):19-27. PubMed ID: 21837368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ in radiation-induced fibrosis.
    Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
    Oncotarget; 2017 Oct; 8(52):90579-90604. PubMed ID: 29163854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin: a therapeutic strategy in cancers by inhibiting the canonical WNT/β-catenin pathway.
    Vallée A; Lecarpentier Y; Vallée JN
    J Exp Clin Cancer Res; 2019 Jul; 38(1):323. PubMed ID: 31331376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermodynamics in cancers: opposing interactions between PPAR gamma and the canonical WNT/beta-catenin pathway.
    Lecarpentier Y; Claes V; Vallée A; Hébert JL
    Clin Transl Med; 2017 Dec; 6(1):14. PubMed ID: 28405929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasculogenesis and angiogenesis initiation under normoxic conditions through Wnt/β-catenin pathway in gliomas.
    Vallée A; Guillevin R; Vallée JN
    Rev Neurosci; 2018 Jan; 29(1):71-91. PubMed ID: 28822229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between the renin-angiotensin system, the canonical WNT/β-catenin pathway and PPARγ in hypertension.
    Vallée A; Lévy BL; Blacher J
    Curr Hypertens Rep; 2018 Jun; 20(7):62. PubMed ID: 29884931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes.
    Liu J; Farmer SR
    J Biol Chem; 2004 Oct; 279(43):45020-7. PubMed ID: 15308623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demyelination in Multiple Sclerosis: Reprogramming Energy Metabolism and Potential PPARγ Agonist Treatment Approaches.
    Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29659554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geraniol ameliorates TNBS-induced colitis: Involvement of Wnt/β-catenin, p38MAPK, NFκB, and PPARγ signaling pathways.
    Soubh AA; Abdallah DM; El-Abhar HS
    Life Sci; 2015 Sep; 136():142-50. PubMed ID: 26165751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARγ agonists: Potential treatments for exudative age-related macular degeneration.
    Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
    Life Sci; 2017 Nov; 188():123-130. PubMed ID: 28887057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARγ agonists: potential treatment for autism spectrum disorder by inhibiting the canonical WNT/β-catenin pathway.
    Vallée A; Vallée JN; Lecarpentier Y
    Mol Psychiatry; 2019 May; 24(5):643-652. PubMed ID: 30104725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells.
    Lee YJ; Han HJ
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1263-75. PubMed ID: 20015942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposite Interplay Between the Canonical WNT/β-Catenin Pathway and PPAR Gamma: A Potential Therapeutic Target in Gliomas.
    Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
    Neurosci Bull; 2018 Jun; 34(3):573-588. PubMed ID: 29582250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions Between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma on Neuroinflammation, Demyelination, and Remyelination in Multiple Sclerosis.
    Vallée A; Vallée JN; Guillevin R; Lecarpentier Y
    Cell Mol Neurobiol; 2018 May; 38(4):783-795. PubMed ID: 28905149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway-PPAR Gamma, Energy Metabolism and Circadian Rhythms.
    Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
    Neuromolecular Med; 2018 Jun; 20(2):174-204. PubMed ID: 29572723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reprogramming energetic metabolism in Alzheimer's disease.
    Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
    Life Sci; 2018 Jan; 193():141-152. PubMed ID: 29079469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necrotizing Enterocolitis: LPS/TLR4-Induced Crosstalk Between Canonical TGF-β/Wnt/β-Catenin Pathways and PPARγ.
    Gomart A; Vallée A; Lecarpentier Y
    Front Pediatr; 2021; 9():713344. PubMed ID: 34712628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.